These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22117341)

  • 61. [Chronic obstructive pulmonary disease and its links with cardiovascular risk factors].
    Mihalache A; Fitting JW; Nicod LP
    Rev Med Suisse; 2015 Nov; 11(495):2151-2, 2154-6. PubMed ID: 26742235
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Osteoporosis].
    Sugimoto T
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1891-6. PubMed ID: 30160893
    [No Abstract]   [Full Text] [Related]  

  • 63. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease.
    Malerba M; Olivini A; Radaeli A; Ricciardolo FL; Clini E
    Curr Med Res Opin; 2016 May; 32(5):885-91. PubMed ID: 26824631
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Secondary osteoporosis. Chronic obstructive pulmonary disease:COPD.].
    Watanabe R; Inoue D
    Clin Calcium; 2018; 28(12):1647-1652. PubMed ID: 30487330
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
    MacNee W
    Ann Med; 2013 May; 45(3):291-300. PubMed ID: 23110517
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systemic manifestations and comorbidities of COPD.
    Barnes PJ; Celli BR
    Eur Respir J; 2009 May; 33(5):1165-85. PubMed ID: 19407051
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Invited lecture: 1. What we have discovered in Hokkaido COPD Cohort Study].
    Nishimura M
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2152-68. PubMed ID: 24228397
    [No Abstract]   [Full Text] [Related]  

  • 69. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?
    Wouters EF; Reynaert NL; Dentener MA; Vernooy JH
    Proc Am Thorac Soc; 2009 Dec; 6(8):638-47. PubMed ID: 20008867
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Osteoporosis in chronic obstructive pulmonary disease].
    Pobeha P; Lazúrová I; Tkácová R
    Vnitr Lek; 2010 Nov; 56(11):1142-9. PubMed ID: 21250492
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Extrapulmonary effects of chronic obstructive pulmonary disease].
    Coronado M; Fitting JW
    Rev Med Suisse; 2005 Nov; 1(41):2680-2, 2685-7. PubMed ID: 16355883
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Mechanisms of development of osteoporosis in patients with chronic obstructive pulmonary disease].
    Klin Med (Mosk); 2011; 89(6):8-12. PubMed ID: 22420187
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nutrition for the malnourished patient with chronic obstructive pulmonary disease: more is better!
    Felbinger TW; Suchner U
    Nutrition; 2003 May; 19(5):471-2. PubMed ID: 12714103
    [No Abstract]   [Full Text] [Related]  

  • 74. [Question 4-9. Nutritional management in chronic obstructive pulmonary disease: the role of anabolic agents].
    Pison C; Cano N; Pichard C
    Rev Mal Respir; 2005 Nov; 22(5 Pt 3):7S88-7S99. PubMed ID: 16340826
    [No Abstract]   [Full Text] [Related]  

  • 75. Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives.
    Clarenbach CF; Thurnheer R; Kohler M
    Expert Rev Respir Med; 2012 Feb; 6(1):37-43. PubMed ID: 22283577
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Elevated QRISK2 score in patients hospitalized for acute exacerbation of COPD versus stable COPD outpatients.
    Pagliaroli E; Mohan D; Padmanaban V; Palange P; Elkin S; Polkey MI
    Int J Cardiol; 2015 Jan; 179():312-4. PubMed ID: 25464473
    [No Abstract]   [Full Text] [Related]  

  • 77. Complex chronic comorbidities of COPD.
    Fabbri LM; Luppi F; Beghé B; Rabe KF
    Eur Respir J; 2008 Jan; 31(1):204-12. PubMed ID: 18166598
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The contribution of radioimaging to the understanding of the pathophysiological mechanisms of chronic obstructive pulmonary diseases (COPD). Part II. Contribution of imaging in the investigation of comorbidities associated with COPD: cardiovascular diseases, lung cancer, skeletal muscle and nervous system disorders].
    Ungurean I; Tudorache V; Mogoşeanu M; Marc M
    Pneumologia; 2010; 59(4):191-4, 196. PubMed ID: 21365800
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study.
    Chen SJ; Liao WC; Huang KH; Lin CL; Tsai WC; Kung PT; Chang KH; Kao CH
    QJM; 2015 Aug; 108(8):633-40. PubMed ID: 25614611
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Should we treat chronic obstructive pulmonary disease as a cardiovascular disease?
    Rabinovich RA; MacNee W
    Expert Rev Respir Med; 2015 Aug; 9(4):459-72. PubMed ID: 26190174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.